References
- Snapper S B, Rosen F S. The Wiskott-Aldrich syndrome protein (WASP): roles in signalling and cytoskeletal organization. Annu Rev Immunol 1999; 17: 905–929
- Nonoyama S, Ochs H D. Wiskott-Aldrich syndrome. Curr Allergy Asthma Rep 2001; 1: 430–437
- Notarangelo L, Notarangelo L D, Ochs H D. WASP and the phenotypic range associated with deficiency. Curr Opin Allergy Clin Immunol 2005; 5: 485–490
- Ochs H D. The Wiskott-Aldrich syndrome. Sem Hematol 1998; 35: 332–345
- Ariga T, Nakajima M, Yoshida J, et al. Confirming or excluding the diagnosis of Wiskott-Aldrich syndrome in children with thrombocytopenia of an unknown etiology. J Pediatr Hematol Oncol 2004; 26: 435–440
- Rimm I J, Rappeport J M. Bone marrow transplantation for Wiskott-Aldrich syndrome. Transplantation 1990; 50: 617–620
- Ozsahin H, Le Deist F, Benkerrou M, et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 1996; 129: 238–244
- Filipovich A H, Stone J V, Tomany S C, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Programme. Blood 2001; 97: 1598–1603
- Inagaki J, Park D G, Kishimoto T, Yoshioka A. Successful unmanipulated haploidentical bone marrow transplantation from a HLA 2-locus-mismatched mother for Wiskott-Aldrich syndrome after unrelated cord blood stem cell transplantation. J Pediatr Hematol Oncol 2005; 27: 229–231
- Knutsen A P, Steffen M, Wassmer K, Wall D A. Umbilical cord blood transplantation in Wiskott-Aldrich syndrome. J Pediatr 2003; 142: 519–523
- Maldonado M S, Muñoz A, Otheo de Tejada E, Roldan E, Aymerich L, Brieva J A. Allogeneic bone marrow transplantation in Wiskott-Aldrich syndrome. Med Clin (Barc) 1993; 258–260
- Megido M, Cesar J M, Maldonado M S, Otheo E, Muñoz A, Navarro J L. Platelet function study after bone marrow transplantation in Wiskott- Aldrich syndrome. Sangre 1993; 38: 233–234
- Fillat C, Español T, Oset M, Ferrando M, Estivill X, Volpini V. Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich Syndrome. Am J Med Genet 2001; 100: 116–121
- Zhu B Q, Zhang M, Blaese R M, et al. The Wiskott-Aldrich syndrome and X linked congenital thrombocytopenia are caused by mutations of the same gene. Blood 1995; 86: 3797–3804
- Ochs H D, Rosen F S. The Wiskott-Aldrich syndrome. Puck Primary Immunodeficiency Diseases: A Molecular and Genetic Approach, H D Ochs, C IE Smith, J M Puck. Oxford University Press. 1999; 292–305
- Sullivan K E. Recent advances our understanding of the Wiskott–Aldrich syndrome. Curr Opin Hematol 1999; 6: 8–14
- Filipovich A H, Shapiro R S, Ramsay K C, et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992; 80: 270–276
- La Nasa G, Pizzati A, Ledda A, Vacca A, Arras M, Contu L. Unrelated bone marrow transplantation in a Wiskott–Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor. Haematologica 1996; 81: 178–181
- Lenarsky C, Weinberg K, Kohn D B, Parkman R. Unrelated donor BMT for Wiskott-Aldrich. Bone Marrow Transplant 1993; 12: 145–147
- Filipovich A H. Stem cell transplantation from unrelated donors for correction of primary immunodeficiencies. Immunol Allergy Clin North Am 1996; 16: 377–392
- Tsuji Y, Imai K, Kajiwara M, et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006; 37: 469–477
- Rimm I J, Rappeport J M. Bone marrow transplantation for the Wiskott–Aldrich syndrome. Transplantation 1990; 50: 617–620
- Brochstein J A, Gillo A P, Ruggiero M, et al. Marrow transplantation from human leucocyte antigen: identical or haploidentical donors for correction of Wiskott-Aldrich syndrome. J Pediatr 1991; 119: 907–912
- Pay S Y, De Martiins D, Forino C, et al. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single center experience confirms efficacy of matched unrelated donor transplantation. Bone Marrow Transplant 2006; 38: 671–679
- Kobayhasi R, Ariga T, Nonoyama S, et al. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan. Br J Haematol 2006; 135: 362–366
- Buckley R H, Schiff S E, Schiff R I, Market L, Williams L V, Roberts J L. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508–516
- Chen H R, Ji S Q, Wang H X, et al. Humanized anti-CD25 monoclonal antibody for prophylaxis of graft versus host disease (GvHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion. Exp Hematol 2003; 31: 1019–1025
- Knutsen A P, Wall D A. Umbilical cord transplantation in severe T cell immunodeficiency disorders: two year experience. J Clin Immunol 2000; 20: 466–476
- Koneto M, Watanabe T, Watanabe H, et al. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease. Int J Hematol 2003; 78: 457–470
- Slatter M A, Bhattacharya A, Flood T J, Abinun N, Cant A J, Gennery A R. Use of two unrelated umbilical cord blood stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome. Pediatr Blood Cancer 2006; 47: 332–334
- Botzug K, Dewey R A, Klein C. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr Opin Mol Ther 2006; 8: 390–395